VistaGen Therapeutics, Inc. (VTGN) financial statements (2021 and earlier)

Company profile

Business Address 343 ALLERTON AVENUE
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. NV
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10411310300
Cash and cash equivalents10411310300
Receivables  0    
Prepaid expense1 00000
Deferred costs0      
Other undisclosed current assets 00100 
Total current assets:10521411310
Noncurrent Assets
Operating lease, right-of-use asset34
Property, plant and equipment0000000
Deferred costs0      
Other noncurrent assets0     0
Other undisclosed noncurrent assets000000 
Total noncurrent assets:4400000
TOTAL ASSETS:10961411410
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1231124
Accounts payable1211112
Accrued liabilities1120011
Employee-related liabilities      1
Deferred revenue1 
Debt0000004
Other undisclosed current liabilities00    9
Total current liabilities:33311217
Noncurrent Liabilities
Long-term debt and lease obligation3400000
Long-term debt, excluding current maturities     0 
Finance lease, liability 0
Capital lease obligations000 0
Operating lease, liability34
Liabilities, other than long-term debt3 00003
Deferred revenue and credits000 
Accounts payable and accrued liabilities      3
Deferred revenue3 
Deferred rent credit  0
Other undisclosed noncurrent liabilities6143220
Total noncurrent liabilities:12943223
Total liabilities:1512743421
Stockholders' equity
Stockholders' equity attributable to parent, including:94(6)771(3)(21)
Preferred stock      0
Common stock0000000
Treasury stock, value(4)(4)(4)(4)(4)(4)(4)
Additional paid in capital31120019216714713368
Accumulated deficit(214)(202)(181)(157)(142)(132)(85)
Other undisclosed stockholders' equity attributable to parent000000 
Total stockholders' equity:94(6)771(3)(21)
TOTAL LIABILITIES AND EQUITY:10961411410

Income statement (P&L) ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Revenue, net 1  
Gross profit:1   1  
Operating expenses(14)(21)(25)(14)(11)(18)(7)
Other undisclosed operating income (loss)(0)     0
Operating loss:(14)(21)(25)(14)(10)(18)(7)
Nonoperating income     0 
Foreign currency transaction gain, before tax     0 
Other nonoperating expense     (0) 
Interest and debt expense  (0)(0)(0)(27)(7)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes0    (2)(0)
Loss from continuing operations before equity method investments, income taxes:(14)(21)(25)(14)(10)(47)(14)
Other undisclosed income from continuing operations before income taxes00     
Loss from continuing operations before income taxes:(14)(21)(25)(14)(10)(47)(14)
Income tax expense(0)(0)(0)(0)(0)(0)(0)
Net loss attributable to parent:(14)(21)(25)(14)(10)(47)(14)
Preferred stock dividends and other adjustments(1)      
Other undisclosed net loss available to common stockholders, basic(0)(1)(1)(1)(1)(4) 
Net loss available to common stockholders, basic:(15)(22)(26)(16)(12)(51)(14)
Other undisclosed net loss available to common stockholders, diluted      (0)
Net loss available to common stockholders, diluted:(15)(22)(26)(16)(12)(51)(14)

Comprehensive Income ($ in millions)

12/31/2020
TTM
3/31/2020
3/31/2019
3/31/2018
3/31/2017
3/31/2016
3/31/2015
Net loss:(14)(21)(25)(14)(10)(47)(14)
Comprehensive loss, net of tax, attributable to parent:(14)(21)(25)(14)(10)(47)(14)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: